Biotech Stock News Bite – NKGen Biotech, Inc. (NASDAQ: NKGN) Makes NASDAQ Top Gainers List March 6, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com) Biotech Stock News Bites – NKGen Biotech, Inc. (NASDAQ: NKGN) made the top percentage gainers liston NASDAQ today, trading at $2.1800, up $1.2582 or 136.4938%mon volume of 103 Million. The day’s high was $4.06. NKGen Biotech, Inc. (Nasdaq: NKGN) , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK Natural Killer (NK) cell therapeutics, recently announced the acceptance of an abstract for presentation on the effect of SNK01 NK cell therapy on CSF proteins, plasma proteins, and cognitive function in patients with advanced Alzheimer’s disease. The data will be presented at the Tau2024 Global Conference, held March 25-26, 2024, virtually and at The Westin Washington, DC Downtown in Washington, D.C. Presentation Details: Abstract Title: Beneficial Effect on CSF and Plasma Tau Proteins and Cognitive Function in Alzheimer’s Disease Subjects Treated with Expanded Non-Genetically Modified Autologous Natural Killer Cells (SNK01) Authors: Clemente Humberto Zuniga Gil, Blanca Isaura Acosta Gallo, Rufino Menchaca Diaz, Cesar Alejandro Amescua, Sean Hong, Lucia Hui, Hank Lee, Juan Mata, Paul Y. Chang, Katia Betito, Paul Y. Song Date: Monday, March 25, 2024 Read the company’s full news and disclaimer here: https://finance.yahoo.com/news/nkgen-biotech-announces-upcoming-presentation-130000183.html Research more Biotech stocks with Investorideas.com stock directory https://www.investorideas.com/BIS/Stock_List.asp About Investorideas.com – Big Investing Ideas Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech , sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed. Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: More disclaimer and disclosure info https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp Follow us on Twitter @investorideas and @stocknewsbites Follow us on Facebook https://www.facebook.com/Investorideas Follow us on YouTube https://www.youtube.com/c/Investorideas Sign up for free stock news alerts at Investorideas.com https://www.investorideas.com/Resources/Newsletter.asp Contact Investorideas.com 800 665 0411
This content was originally published here.